会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • METHOD FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLE
    • 使用MICRONEEDLE将药物递送至眼用组织的方法
    • US20070260201A1
    • 2007-11-08
    • US11743535
    • 2007-05-02
    • Mark PrausnitzNinghao JiangHenry Edelhauser
    • Mark PrausnitzNinghao JiangHenry Edelhauser
    • A61M5/32
    • A61F9/0017A61M2037/0061
    • Methods and devices are provided for administering a drug to a patient's eye. The methods include (a) inserting a hollow microneedle into the sclera or corneal stroma without penetrating across the sclera or corneal stroma; and (b) infusing a fluid drug formulation through the microneedle and into the sclera or cornea. It further may include partially retracting the microneedle before infusion to enhance delivery. Alternatively, the methods may include (a) inserting a solid microneedle into the sclera or corneal stroma without penetrating across the sclera or corneal stroma, wherein the solid microneedle comprises a first quantity of a drug formulation and inserting causes the solid microneedle to form a pocket in the sclera or corneal stroma; and (b) releasing the drug formulation into the pocket to form a drug depot, whereby a drug is released from the depot. The methods and devices may include an array of multiple microneedles.
    • 提供了用于向患者的眼睛施用药物的方法和装置。 所述方法包括(a)将中空微针插入巩膜或角膜基质中而不穿透巩膜或角膜基质; 和(b)将流体药物制剂通过微针注入巩膜或角膜。 它还可以包括在输注之前部分缩回微针以增强递送。 或者,所述方法可以包括(a)将固体微针插入巩膜或角膜基质中而不穿透巩膜或角膜基质,其中固体微针包含第一量的药物制剂并且插入导致固体微针形成口袋 在巩膜或角膜基质中; 和(b)将药物制剂释放到口袋中以形成药物库,由此从药剂库释放药物。 所述方法和装置可以包括多个微针的阵列。
    • 8. 发明申请
    • Assessment and control of acoustic tissue effects
    • 评估和控制声学组织的影响
    • US20070073197A1
    • 2007-03-29
    • US11556074
    • 2006-11-02
    • Mark PrausnitzJin LiuThomas Lewis
    • Mark PrausnitzJin LiuThomas Lewis
    • A61H1/00A61H1/02
    • A61K41/0023A61B5/14532A61K41/0047A61M37/0092
    • A method for reversibly, or irreveribly, altering the permeability of cells, tissues or other biological barriers, to molecules to be transported into or through these materials, through the application of acoustic energy, is enhanced by applying the ultrasound in combination with means for monitoring and/or implementing feedback controls. The acoustic energy is applied directly or indirectly to the cells or tissue whose permeability is to be altered, at a frequency and intensity appropriate to alter the permeability to achieve the desired effect, such as the transport of endogenous or exogenous molecules and/or fluid, for drug delivery, measurement of analyte, removal of fluid, alteration of cell or tissue viability or alteration of structure of materials such as kidney or gall bladder stones. In the preferred embodiment, the method includes measuring the strength of the acoustic field applied to the cell or tissue at the applied frequency or other frequencies, and using the acoustic measurement to modify continued or subsequent application of acoustic energy to the cell or tissue. In another preferred embodiment, the method further includes simultaneously, previously, or subsequently exposing the cell or tissue to the chemical or biological agent to be transported into or across the cell or tissue. In another preferred application, the method includes removing biological fluid or molecules from the cell or tissue simultaneously, previously or subsequently to the application of acoustic energy and, optionally, assaying the biological fluid or molecules.
    • 通过应用声能来结合使用超声波手段来增强通过施加声能可逆地或不可逆地地将细胞,组织或其它生物屏障的透过性改变为要被输送入或穿过这些材料的分子的方法 和/或实施反馈控制。 将声能直接地或间接地施加到要改变其渗透性的细胞或组织,其频率和强度适于改变渗透性以实现所需的效果,例如内源性或外源性分子和/或流体的转运, 用于药物递送,分析物的测量,流体的去除,细胞或组织的活力的改变或材料如肾或胆囊结石的结构的改变。 在优选实施例中,该方法包括以施加的频率或其他频率来测量施加到细胞或组织的声场的强度,并且使用声学测量来修改对细胞或组织的声能的持续或随后的应用。 在另一个优选的实施方案中,该方法还包括同时,预先或随后将细胞或组织暴露于待转运至细胞或组织中的化学或生物试剂。 在另一个优选的应用中,该方法包括在预先或随后施加声能并且任选地测定生物流体或分子的同时,从细胞或组织中移除生物流体或分子。